Our human brain homogenate is prepared from ethically sourced, non-diseased human brain tissue and processed under controlled conditions to preserve native enzymatic and biochemical activity. This homogenate contains both cytosolic and membrane-bound components, making it a versatile in vitro system for studying central nervous system (CNS) drug metabolism, neurotoxicity, and biochemical pathways relevant to brain function.
Human brain homogenate is suitable for use in early-stage neuropharmacology, enzyme profiling, biomarker discovery, and compound screening, offering a reliable matrix for translational neuroscience research and CNS-targeted drug development.